# E.N.D.E.A.V.O.R.: An Exemestane Needed Dose Efficacy and Verification as an Ovulation Induction Regimen Study

> **NCT07706374** · PHASE1 · RECRUITING · sponsor: **University of North Carolina, Chapel Hill** · enrollment: 40 (estimated)

## Conditions studied

- Poly Cystic Ovary Syndrome

## Interventions

- **DRUG:** Exemestane 25 MG
- **DRUG:** Placebo
- **DRUG:** Exemestane 50 MG

## Key facts

- **NCT ID:** NCT07706374
- **Lead sponsor:** University of North Carolina, Chapel Hill
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-10-01
- **Primary completion:** 2028-12
- **Final completion:** 2030-01
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-09-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706374

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706374, "E.N.D.E.A.V.O.R.: An Exemestane Needed Dose Efficacy and Verification as an Ovulation Induction Regimen Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07706374. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*